Key Insights• China operates the world's largest single-payer health financing architecture, anchored by basic medical insurance that covered over 1.33 billion people at the end of 2025, with the coverage rate stable at approximately 95 percent. The basic medical insurance fund, including maternity insurance, recorded nearly RMB 3.59 trillion in revenue and RMB 3.0 trillion in expenditure in 2025. This scale of pooled financing creates the transaction and reconciliation volume on which healthcare fintech platforms operate.• Total health expenditure reached RMB 9.3367 trillion in 2025, representing 6.7 percent of GDP, with government health expenditure at RMB 2.35 trillion (25.2 percent), social health expenditure at RMB 4.46 trillion (47.7 percent), and personal health expenditure at RMB 2.53 trillion (27.1 percent). The 27.1 percent out-of-pocket share remains structurally significant, sustaining direct patient payment, installment financing, and digital collection as core fintech use cases.• The provider base is vast and increasingly digitised at the clinical level. China recorded 1,108,335 healthcare institutions and 10.65 billion total patient visits in 2025, including 2.991 billion inpatient discharges. Hospitals numbered 38,159, of which 11,678 were public and 26,481 were private, with private hospitals accounting for 30.1 percent of hospital beds.

This dual public-private provider structure creates distinct financial workflows across insurance reimbursement and self-pay channels.• Commercial health insurance has crossed the trillion-yuan threshold, reaching RMB 997.3 billion in premium income in 2025, with medical insurance products alone contributing approximately RMB 455 billion. The National Financial Regulatory Administration has identified commercial health insurance as an “effective complement” to basic insurance, particularly as DRG/DIP reforms clarify the boundaries of social insurance coverage and create demand for supplemental and special-needs products.Market Outlook• According to the Actual Market Research report, “China Healthcare Fintech Market Outlook, 2031,” published by Actual Market Research, the China healthcare fintech market is anticipated to grow at more than 11.96 % CAGR from 2026 to 2031. Expansion is supported by the scale of basic insurance settlement flows, the rapid adoption of medical insurance code and mobile payment infrastructure, the growth of commercial health insurance, and the digitalisation of provider revenue cycles under DRG/DIP reform.• Provider revenue cycle and payment fintech is expected to remain a foundational segment. The DRG/DIP reform has shifted provider incentives from volume to cost efficiency, requiring hospitals to invest in claims validation, cost accounting, and reimbursement analytics. The 91.8 percent penetration of disease-based payment means that virtually every insured inpatient discharge now flows through a standardised payment logic that demands automated financial reconciliation.• Patient care financing is expected to expand as the 27.1 percent out-of-pocket share persists and private providers seek to convert deferred treatment into paid procedures. Consumer credit for medical services, clinic-based installment plans, and digital point-of-care financing are becoming embedded in private hospital and specialty clinic workflows, supported by the national push toward credit payment in healthcare settings.• AI-enabled financial workflows are expected to reshape the competitive landscape. The National Health Commission and four other ministries issued the implementation opinion on “AI + Healthcare” in November 2025, setting targets for AI-assisted primary care, clinical decision support, and smart patient services by 2027 and full integration by 2030.

These capabilities extend into claims validation, fraud detection, and revenue cycle analytics.Market DynamicsDriver: Basic Insurance Scale and the DRG/DIP Revenue Cycle TransitionThe Chinese healthcare fintech market is shaped by the sheer scale of basic insurance settlement flows and the structural transition to disease-based payment. With 1.33 billion insured lives, 7.215 billion outpatient visits covered by the schemes in 2025, and 278 million inpatient treatments, the financial reconciliation workload is enormous. The DRG/DIP reform, now covering 91.8 percent of insured inpatient discharges, has shifted provider revenue realisation from fee-for-service billing to standardised disease-based payment, requiring hospitals to validate claims, manage cost variance, and reconcile reimbursement against budgeted payment weights. The August 2025 Interim Measures further standardise grouping, budget management, and core payment elements, creating a more predictable but more analytically demanding financial environment for providers.Challenge: Fragmented Provider Digital Maturity and Anti-Fraud ComplianceA significant challenge is the uneven digital maturity of providers, particularly the 26,481 private hospitals and the large base of primary care institutions. While tertiary public hospitals have achieved high electronic medical record adoption, smaller private and grassroots providers lag in financial system integration, limiting the automation of claims, reimbursement, and treasury reconciliation. Anti-fraud compliance adds a further burden: the National Healthcare Security Administration recovered RMB 34.2 billion in medical insurance funds in 2025 and inspected 905,000 designated institutions, and the “Hundred-Day Campaign” targeting insurance fraud has intensified scrutiny of claims and prescription patterns.

Platforms must embed fraud detection and audit trails into financial workflows to remain compliant, increasing development and operational costs.Trend: Medical Insurance Code, Mobile Payment, and Credit Payment IntegrationThe market is experiencing a shift toward code-based, mobile, and credit payment integration across the patient financial journey. The medical insurance code has processed 12 billion cumulative settlements and is connected to over 930,000 institutions. Mobile payment is live at 47,000 institutions, and the NHSA’s December 2025 notice explicitly promotes face-scan payment, one-code payment, mobile payment, and credit payment across healthcare scenarios. Credit payment is particularly significant for patient financing: in Guangdong province alone, 800 designated institutions have enabled credit payment, with banks advancing the self-pay portion and patients paying after treatment, accumulating 9.66 million settlements worth RMB 1.5 billion. This model embeds financing directly into the clinical workflow and reduces the upfront payment barrier for patients.Policies• The National Healthcare Security Administration administers basic medical insurance, including fund supervision, payment reform, and the medical insurance code infrastructure. The 2025 fund revenue reached nearly RMB 3.59 trillion, and the agency recovered RMB 34.2 billion in fraud-related funds through enhanced oversight.• The Interim Measures for Disease-based Payment Management, issued by the NHSA in August 2025, standardise DRG/DIP grouping, budget management, and core payment elements.

Disease-based payment covered 91.8 percent of insured inpatient discharges in 2025, and the measures require grouping adjustments at least every two years.• The National Standard GB/T 45938 2025, issued by the State Administration for Market Regulation and developed by the NHSA, specifies technical requirements for medical insurance code, mobile payment, electronic prescription, and authorised personal information query. It took effect on 1 January 2026 and applies to designated institutions, financial institutions, and third-party payment providers.• The NHSA Office’s December 2025 notice on promoting convenient payment explicitly directs the rollout of face-scan payment, one-code payment, mobile payment, and credit payment across healthcare scenarios, with a timeline of initial results in 2026, provincial coverage by 2027, and full implementation by 2028.• The National Health Commission and four other ministries issued the implementation opinion on “AI + Healthcare” in November 2025, setting targets for AI-assisted primary care and clinical decision support by 2027 and full integration by 2030, with implications for claims validation, fraud detection, and financial analytics.Segment AnalysisChina Healthcare Fintech Market By Solution• Provider Revenue Cycle and Payment Fintech: A foundational segment encompassing billing, claims submission, DRG/DIP reimbursement reconciliation, and payment processing for public and private hospitals. The segment is driven by the 91.8 percent penetration of disease-based payment, the RMB 3.0 trillion basic insurance expenditure base, and the need to validate claims and manage cost variance under standardised payment weights. The transition from fee-for-service to DRG/DIP has made revenue cycle analytics a core operational requirement rather than a back-office function.• Patient Care Financing: A growing segment driven by the 27.1 percent out-of-pocket share and the expansion of credit payment in healthcare. Banks and fintech platforms are embedding installment and credit payment directly into hospital and pharmacy workflows, with Guangdong’s credit payment model accumulating 9.66 million settlements worth RMB 1.5 billion. The model reduces upfront payment barriers and converts deferred demand into realised revenue.• Consumer-Directed Healthcare Accounts and Benefit Payment Platforms: An emerging segment as commercial insurers, employers, and providers digitise benefit disbursement and member financial engagement.

The RMB 997.3 billion commercial health insurance market and the RMB 455 billion medical insurance product segment create a payer-funded benefit pool, while medical insurance mobile payment and credit payment infrastructure provide the rails for account-linked payment and reimbursement.China Healthcare Fintech Market By Economic Buyer• Healthcare Providers: A major economic buyer group, encompassing 38,159 hospitals and over one million healthcare institutions. Providers invest in billing, claims validation, and DRG/DIP reconciliation to manage the transition to disease-based payment, with tertiary public hospitals leading adoption and private and grassroots providers lagging in digital maturity.• Healthcare Payers and Insurers: A significant economic buyer group, encompassing the National Healthcare Security Administration and commercial health insurers. The NHSA administers RMB 3.0 trillion in annual expenditure and invests in fraud detection, payment reform infrastructure, and medical insurance code systems. Commercial insurers, with RMB 997.3 billion in premiums, invest in claims automation, product design, and member financial engagement tools.China Healthcare Fintech Market Economics• Healthcare fintech pricing varies by segment and provider size. Provider billing and claims platforms typically charge per-institution subscription fees plus transaction fees for claims submission and DRG/DIP reconciliation. Patient financing platforms earn origination and servicing income, or operate through bank-embedded credit payment models where the bank advances the self-pay portion and assumes credit risk.• The economic case for DRG/DIP reconciliation automation is anchored in the scale of disease-based payment and the complexity of cost variance management.

With 91.8 percent of insured inpatient discharges flowing through standardised payment weights, providers face substantial analytical and reconciliation workloads, and platforms that can automate claims validation and cost accounting have a clear value proposition.• Patient financing economics are shaped by credit risk, bank partnerships, and regulatory constraints. The credit payment model in Guangdong, where banks advance the self-pay portion and patients pay after treatment, illustrates how financing can be embedded into the clinical workflow without requiring the provider to bear credit risk.• Adoption economics are constrained by provider fragmentation and digital maturity gaps. Large tertiary hospitals have the volume and capital to invest in integrated financial systems, while private hospitals and grassroots institutions require low-cost, cloud-based or mobile-first solutions with rapid payback periods.Considered in this report• Historic Year: 2020• Base year: 2025• Estimated year: 2026• Forecast year: 2031Aspects covered in this report• Healthcare Fintech Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Solution• Provider Revenue Cycle and Payment Fintech• Payer Claims and Payment Automation Fintech• Patient Care Financing• Health Insurance Premium Financing• Consumer-Directed Healthcare Accounts and Benefit Payment Platforms• Healthcare Financial Management and Working Capital FintechBy Economic Buyer• Healthcare Providers• Healthcare Payers• Patients and Individual Consumers• Employers and Plan SponsorsBy Deployment Mode• Cloud-Based• On-Premises• Hybrid.